A carregar...

Retrospective Analysis of Eculizumab in Patients with Acetylcholine Receptor Antibody-Negative Myasthenia Gravis: A Case Series

BACKGROUND: The role of the complement cascade in acetylcholine receptor antibody-negative (AChR–) myasthenia gravis (MG) is unclear. OBJECTIVE: To assess the efficacy and tolerability of eculizumab (terminal complement inhibitor) in patients with AChR–MG. METHODS: Retrospective chart review of data...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neuromuscul Dis
Main Authors: Datta, Sorabh, Singh, Shivangi, Govindarajan, Raghav
Formato: Artigo
Idioma:Inglês
Publicado em: IOS Press 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7369065/
https://ncbi.nlm.nih.gov/pubmed/32444555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JND-190464
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!